Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Myeloma 2014 /
Myeloma genomics and Immuno-oncology

20th May 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.05.14
Views: 2512

Prof Keith Stewart; Prof Gareth Morgan; Dr Leif L. Bergsagel; Prof Antonio Palumbo

Prof Stewart  (Mayo Clinic, Scottsdale, USA) chairs a discussion with Prof Morgan (The Royal Marsden Hospital, London, UK), Dr Bergsagel (Mayo Clinic, Scottsdale, Arizona), and Prof Antonio Palumbo (University of Torina, Torina, Italy) for ecancertv at Myeloma 2014, about the treatment of myeloma.

They discuss the clinical implications and strategies to overcome clonal heterogeneity, genomics and practice, early treatment, immune based therapy, and new insights in IMiD drug sensitivity and resistance.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation